Overview

A Study Investigating the Pharmacokinetics of FV-100 With and Without Ritonavir in Healthy Volunteers

Status:
Completed
Trial end date:
2015-07-01
Target enrollment:
Participant gender:
Summary
This study is designed to evaluate the potential for a PK drug-drug interaction between FV-100 and ritonavir. The study is a single-center, open-label, randomized, 2-way crossover design in healthy volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
ContraVir Pharmaceuticals, Inc.
Treatments:
Ritonavir